scispace - formally typeset
A

Abba C. Zubair

Researcher at Mayo Clinic

Publications -  77
Citations -  2303

Abba C. Zubair is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Mesenchymal stem cell & Medicine. The author has an hindex of 21, co-authored 60 publications receiving 1807 citations.

Papers
More filters
Journal ArticleDOI

Massive gliosis induced by interleukin-6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition

TL;DR: Results indicate that mIL‐6‐mediated reactive gliosis may be beneficial early in the disease process by potentially enhancing Aβ plaque clearance rather than mediating a neurotoxic feedback loop that exacerbates amyloid pathology.
Journal ArticleDOI

Translation initiator EIF4G1 mutations in familial Parkinson disease

Marie-Christine Chartier-Harlin, +59 more
TL;DR: Genome-wide analysis of a multi-incident family with autosomal-dominant parkinsonism has implicated a locus on chromosomal region 3q26-q28 and highlighted a convergent pathway for monogenic, toxin and perhaps virally-induced Parkinson disease.
Journal ArticleDOI

A Prospective, Single-Blind, Placebo-Controlled Trial of Bone Marrow Aspirate Concentrate for Knee Osteoarthritis

TL;DR: Early results show that BMAC is safe to use and is a reliable and viable cellular product and study patients experienced a similar relief of pain in both BMAC- and saline-treated arthritic knees.
Journal ArticleDOI

Pathway analysis of primary central nervous system lymphoma

TL;DR: The gene expression signature discovered in this study may represent a true "CNS signature" because it contrasted PCNSL with wide-spectrum non-CNS DLBCL on a genomic scale and performed an in-depth bioinformatic analysis.
Journal ArticleDOI

Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growth.

TL;DR: Tumour cell–derived EVs can contribute to the generation of tumour stroma through fibroblastic differentiation of MSCs, and can also selectively modulate the cellular release of soluble factors such as IL-6 by M SCs that can, in turn, alter tumour cell proliferation.